News - Pharmaceuticals
Women’s Health Week series: Merck Healthcare MD talks key trends impacting the equity of access to infertility care

In celebrating Women’s Health Week (5 – 11 September), this interview in a series called Women, Equity and Health will focus on women and infertility.
Josie Downey, General Manager and Managing Director of Merck Healthcare ANZ, joined Health Industry Hub to address the key barriers in care experienced by Australian women and families seeking infertility services and treatments.
Josie shared her insights on the current gaps in infertility clinical trials and discussed how the company is partnering with stakeholders to also increase diversity among clinical trial participants to better mirror the communities we live in.
When reflecting on inequities in infertility care delivery, Josie discussed the impact of the current models of care and how limitations in availability and access to infertility care is amplified for minority groups.
In considering the Health Technology Assessment (HTA) Review, Josie shared her views on the reforms that are most relevant to the infertility sector to ensure there is more equitable patient access to treatments in Australia.
News - Pharmaceuticals
New vaccine guidelines risk further decline in immunisation
The intensifying political and public scrutiny of Dr Anthony Fauci has become emblematic of a wider struggle over trust in […]
MoreNews - Pharmaceuticals
The weight of the wait: GLP-1 boom hits PBS roadblock
More than one million Australians have been dispensed a GLP-1 receptor agonist over the past five years, accelerating the emergence […]
MoreNews - MedTech & Diagnostics
As insurer blame game escalates, patients miss out on the promise of private health
The Age and Sydney Morning Herald’s investigation into the Prescribed List (PL) and the pricing of medical devices has drawn […]
MoreLeadership & Management
David Henderson appointed Takeda Oceania Country Head
David Henderson has been appointed Country Head for Takeda Oceania, succeeding Dave Pearce, as the pharmaceutical company continues to reshape […]
More